A case study on how a leading pharma company in hematology turned to DelveInsight for long-term competitive intelligence support. DelveInsight provided an in-depth analysis of competitive activity in key hematological malignancies, helping the company stay […]
Advances in immunotherapy have ushered in a new era of treatment for follicular lymphoma (FL), particularly for patients who have experienced relapse after conventional chemotherapy regimens. This paradigm shift is characterized by the emergence of […]
An increase in research and development (R&D) activities in myotonic dystrophy is expected to drive market growth by enhancing the understanding of the disease, accelerating drug discovery, and creating innovative treatments. With more R&D, new […]
According to DelveInsight’s analysis, the chronic refractory cough market size is expected to increase due to an increase in disease prevalence, the growth in the market of currently approved products, and the expected launch of […]
The dermatological drugs market is experiencing notable growth, driven by the increasing prevalence of skin conditions worldwide. Additionally, factors such as heightened awareness of skin health, growing spending on skincare and personal care, a rising […]
